31
Jul
The FDA’s Janet Woodcock may be Sarepta CEO Chris Garabedian’s favorite person today.
Source: Muscular dystrophy biotechs buoyed by FDA’s encouragement on accelerated OKs
The FDA’s Janet Woodcock may be Sarepta CEO Chris Garabedian’s favorite person today.
Source: Muscular dystrophy biotechs buoyed by FDA’s encouragement on accelerated OKs
